SFM
BLACR

Spartan Fund Management’s Bellevue Life Sciences Acquisition Corp. Rights BLACR Stock Holding History

Spartan Fund Management’s Portfolio BLACR Stock Details BLACR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-69,076
Closed -$9.88K – 110
2024
Q1 		$9.88K Sell
69,076
-89,400
-56% -$12.8K 0.02% 71
2023
Q4 		$28.1K Sell
158,476
-41,524
-21% -$7.37K 0.03% 87
2023
Q3 		$56K Sell
200,000
-30,528
-13% -$8.55K 0.04% 113
2023
Q2 		$92K Buy
+230,528
New +$92K 0.02% 156